173 related articles for article (PubMed ID: 16268422)
21. Noncompliance in organ transplant recipients.
Rovelli M; Palmeri D; Vossler E; Bartus S; Hull D; Schweizer R
Transplant Proc; 1989 Feb; 21(1 Pt 1):833-4. PubMed ID: 2650282
[No Abstract] [Full Text] [Related]
22. [Mechanisms of action of immunosuppressive drugs in organ transplantation].
Manfro RC; Gonçalves LF; Barros E; Prompt CA
Rev Assoc Med Bras (1992); 1992; 38(2):111-6. PubMed ID: 1307065
[No Abstract] [Full Text] [Related]
23. Immunosuppression: practice and trends.
Helderman JH; Bennett WM; Cibrik DM; Kaufman DB; Klein A; Takemoto SK
Am J Transplant; 2003; 3 Suppl 4():41-52. PubMed ID: 12694049
[No Abstract] [Full Text] [Related]
24. Religious reasons for discontinuation of immunosuppressive medications after renal transplant.
Subach RA; Abul-Ezz SR
Ren Fail; 1999 Mar; 21(2):223-6. PubMed ID: 10088183
[TBL] [Abstract][Full Text] [Related]
25. Immunopharmacologic therapy in renal transplantation.
Shoker AS
Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
[TBL] [Abstract][Full Text] [Related]
26. Corticosteroid elimination in pediatric solid organ transplantation.
Fine RN; Otte JB; Tejani A
Pediatr Transplant; 1998 Feb; 2(1):3-5. PubMed ID: 10084753
[No Abstract] [Full Text] [Related]
27. Treatment. Organ rejection drugs effective against HIV.
AIDS Policy Law; 2014 May; 29(6):1. PubMed ID: 25087233
[No Abstract] [Full Text] [Related]
28. Some observations on prope tolerance.
Calne R; Watson CJ
Curr Opin Organ Transplant; 2011 Aug; 16(4):353-8. PubMed ID: 21666472
[TBL] [Abstract][Full Text] [Related]
29. Refining the definition and management of high-risk organ transplant recipients.
Hricik DE
Curr Opin Organ Transplant; 2009 Dec; 14(6):634-5. PubMed ID: 19920762
[No Abstract] [Full Text] [Related]
30. Evolving immunosuppressive regimens for lung transplant recipients.
Meyer NJ; Bhorade SM
Semin Respir Crit Care Med; 2006 Oct; 27(5):470-9. PubMed ID: 17072795
[TBL] [Abstract][Full Text] [Related]
31. [Recent options in drug therapy after solid organ transplantation].
Pőcze B; Németh P; Langer R
Orv Hetil; 2012 Aug; 153(33):1294-301. PubMed ID: 22890176
[TBL] [Abstract][Full Text] [Related]
32. Minimisation of immunosuppression in transplantation.
Calne RY; Lee KO
Lancet; 2007 Aug; 370(9588):654; author reply 654. PubMed ID: 17720011
[No Abstract] [Full Text] [Related]
33. Generic immunosuppression in transplantation: current evidence and controversial issues.
El Hajj S; Kim M; Phillips K; Gabardi S
Expert Rev Clin Immunol; 2015 May; 11(5):659-72. PubMed ID: 25817258
[TBL] [Abstract][Full Text] [Related]
34. Tolerance induction.
Kupiec-Weglinski JW
Curr Opin Organ Transplant; 2008 Aug; 13(4):331-2. PubMed ID: 18685325
[No Abstract] [Full Text] [Related]
35. The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation.
Magliocca JF; Knechtle SJ
Transpl Int; 2006 Sep; 19(9):705-14. PubMed ID: 16918530
[TBL] [Abstract][Full Text] [Related]
36. Noncompliance in organ transplant recipients: a literature review.
Laederach-Hofmann K; Bunzel B
Gen Hosp Psychiatry; 2000; 22(6):412-24. PubMed ID: 11072057
[TBL] [Abstract][Full Text] [Related]
37. Parallel universes.
Hanauer SB
Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):411. PubMed ID: 17667991
[No Abstract] [Full Text] [Related]
38. Immunosuppressive Therapy in Transplantation.
Allison TL
Nurs Clin North Am; 2016 Mar; 51(1):107-20. PubMed ID: 26897428
[TBL] [Abstract][Full Text] [Related]
39. Profiles of noncompliance in patients with a functioning renal transplant: a multicenter study. Compliance Study Group.
Siegal B; Greenstein SM
Transplant Proc; 1999; 31(1-2):1326-7. PubMed ID: 10083591
[No Abstract] [Full Text] [Related]
40. [Immunosuppression after organ transplantation].
Wagner K; Erhard J
Zentralbl Chir; 1992; 117(12):648-52. PubMed ID: 1285470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
